WO2003028673A1 - Cosmetic preparation - Google Patents

Cosmetic preparation Download PDF

Info

Publication number
WO2003028673A1
WO2003028673A1 PCT/JP2002/009269 JP0209269W WO03028673A1 WO 2003028673 A1 WO2003028673 A1 WO 2003028673A1 JP 0209269 W JP0209269 W JP 0209269W WO 03028673 A1 WO03028673 A1 WO 03028673A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
cedrol
oil
acid
cosmetic
Prior art date
Application number
PCT/JP2002/009269
Other languages
French (fr)
Japanese (ja)
Inventor
Atsushi Suzumatsu
Hikaru Sumida
Toshio Uesaka
Kimihiko Hori
Mami Nonomura
Original Assignee
Kao Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corporation filed Critical Kao Corporation
Publication of WO2003028673A1 publication Critical patent/WO2003028673A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Definitions

  • the present invention relates to a cosmetic composition in which the transdermal absorbability of cedrol is improved and the antiallergic (IL4 production suppression) action is excellent.
  • the surface of the skin is covered with the stratum corneum, and has a structure that prevents the invasion of foreign substances from outside the body.
  • Sufficient transdermal absorbability can be obtained simply by incorporating the active ingredient into cosmetics. hard.
  • various percutaneous absorption enhancers for example, polar compounds such as dimethyl sulfoxide, N-methylpyrrolidone, and methyl sorbate have been proposed (Japanese Patent Application Laid-Open No. 61-331129).
  • these transdermal absorption enhancers are excellent in transdermal absorption, they are not sufficient in terms of irritation, stability, and feeling of use.
  • cedrol has an antiallergic action due to its excellent inhibitory action on IL4 production (Japanese Unexamined Patent Publication No. 2000-3099528).
  • IL4 production Japanese Unexamined Patent Publication No. 2000-3099528
  • transdermal absorption of cedrol into the stratum corneum was not sufficient.
  • An object of the present invention is to provide a cosmetic composition in which the transdermal absorbability of cedrol is improved, the effect of cedrol can be sufficiently exerted, and there is no irritation. Disclosure of the invention
  • the inventor of the present invention has found that, when an oil agent having a specific SP value range is used in combination with Cedokul, cedrol can be stably compounded, and at the same time, the antiallergic (IL4 production inhibitory) action of a cosmetic containing cedrol is further enhanced.
  • the present invention comprises the following components (A) and (B):
  • Cedrol of component (A) used in the cosmetic of the present invention is a kind of sesquiterpene alcohol, and has an optical isomer, but is generally a (d) isomer represented by the formula (1).
  • d isomer represented by the formula (1).
  • the (d) isomer is preferred, but the optical isomer (1) or the (d) isomer
  • Cedrol is generally known as a fragrance component contained in essential oils of plants such as Pinaceae, Cedars, Cypresses, Scorpiones, Prunus, etc. It can be obtained by purifying essential oils such as fern wood oil and hiba oil by distillation or the like, and can also be obtained by synthesis. As the cedrol used in the present invention, any of the above-mentioned essential oil products and synthetic products may be used, or a commercially available product may be used.
  • Cedrol of the component (A) is contained in the cosmetic of the present invention in an amount of 0.01 to 10% by weight, particularly 0.1 to 5% by weight. / 0 is preferable because an antiallergic effect can be effectively exerted.
  • the oil agent of the component (B) used in the cosmetic of the present invention has a total carbon number of 22 or more. 7 to 21 things.
  • the SP value is obtained by the method for obtaining the dissolution parameters described on pages 78 to 78 of “Solutions and Solubility, 3rd Edition” by Kozo Shinoda (Maruzen Co., Ltd., 1991).
  • the total carbon number of the oil agent of the component ( ⁇ ) is 22 or more, and particularly preferably 22 to 40, Further, the SP value at 25 ° C is preferably from 17 to 21, particularly preferably from 17.0 to 19.0.
  • Specific examples of the component (B) include d 1 - ⁇ -tocopherol (total carbon number 29: SP value (25 ° C) 19.4 (the same applies hereinafter)), glyceryl monoisostearate and glyceryl monomyristate (35: 18.4), diisostearyl malate (40:
  • glyceryl triisostearate (57: 17.2), diglyceryl triisostearate (60: 18.0), trimethylpropane triisostearate (65: 17.2), glyceryl trioctanoate (57:17) 7), glyceryl tricaprate (33: 17.8), polyoxyethylene pyrostearate isostearate (25) glyceryl ether (175: 205), polyoxyethylene pionate (2) myristyl ether (23) : 17.3), polyoxyethylene myristate (3) myristyl ether (34: 17.5), dioctyldodecyl lauroylglutamate (57: 17.5), cetyl ricinolate (34: 18.0), ricinolein Acid tetrahydrofurfuryl (28:
  • polyglyceryl disostearate (42: 17.0), polyglyceryl disostearate (42-192:
  • component (B) glyceryl monomyristate monoisostearate, diisostearyl malate, neopentyl alcohol dicaprate, propylene glycol dicaprate, propylene glycol dinonanoate, decyltetradecaate are particularly preferred.
  • Two or more types of oil agents of component (B) may be used in combination. Further, in the cosmetic of the present invention 0. 0 0 1-5 0 weight 0/0, especially 0. 0 1-2 0 weight 0/0 preferably contained. In the cosmetic of the present invention, disodium edetate, sodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, dalconic acid, etc. can be used to appropriately contain an oil agent other than the component (B).
  • the cosmetics of the present invention also contain components commonly used in external preparations for skin such as cosmetics, for example, humectants, antioxidants, ultraviolet absorbers, surfactants, thickeners, alcohols, and organic compounds. Acids, alkalis, powder components, coloring agents, aqueous components, water, fragrances, various skin nutrients, and the like can be appropriately contained as necessary.
  • the cosmetic of the present invention can be produced according to a usual method, for example, cream, 9 Can be used as cosmetics such as emulsions, lotions, packs, and jewels.
  • composition A cosmetic having the following composition was prepared by a conventional method, and its transdermal absorption and irritation were evaluated.
  • Composition Cedrol 0 1 (wt 0/0) oil (Table 1) 2
  • a patch test patch with a hole diameter of 16 mm was applied to the upper arm of panelists (10 persons), and 200 L of the sample was applied. After the application, the pansoil was peeled off for 6 hours, and then the applied portion was tape-striped 10 times with a cellophane tape, and the amount of cedrol in the stratum corneum adhered to the cellophane tape was measured.
  • the quantification of cedrol was measured by gas chromatography of an ethanol extract from 10 cellophane tapes.
  • the percutaneous absorption rate was determined by the following formula, and was determined according to the criteria.
  • Example 6 (Emulsion) Cedrol 0 Polyglyceryl diisostearate 25 Glyceryl monoisostearate 25 Glyceryl monomyristate 25 Polyoxyethylene (20) hydrogenated castor oil 2 Methyl polysiloxane (6 cs) 0 5 Cholesterol 0 2 Cholesteryl disostearate 0 1 Cetinoreanoconore 0 3 Stearyl alcohol 0 2 Glycerin 0 Carboxyvinyl polymer
  • Example 7 (Giel) Cedrol 0.1 Diisostearyl malate 4 Polyoxyethylene (40) hydrogenated castor oil 0.2
  • Example 1 1 (water-in-oil cream) Cedrol 0.5 0.5 glyceryl tricaprylate 1.5 kN. Dextrin noremitate 1 N-lauroyl mono-L-glutamic acid
  • Siloxane copolymer 1 Polyoxyethylene tristearyl phosphate (15) Hardened castor oil 1
  • the cosmetic composition of the present invention has improved percutaneous absorption of cedrol, has excellent antiallergic (IL 4 production inhibition) action, and has no irritation.

Abstract

A cosmetic preparation which contains the following ingredients (A) and (B): cedrol and an oil having a total carbon number of 22 or larger and an SP value of 17 to 21. The cosmetic preparation has improved percutaneous cedrol absorbability and excellent antiallergic (IL4 production inhibitory) activity and is not irritative.

Description

明細書 化粧料 技術分野  Description Cosmetic Technical Field
本発明は、セドロールの経皮吸収性が向上し、抗アレルギー( I L 4産生抑制) 作用に優れた化粧料に関する。 背景技術  The present invention relates to a cosmetic composition in which the transdermal absorbability of cedrol is improved and the antiallergic (IL4 production suppression) action is excellent. Background art
一般に、 皮膚の表面 (表皮) は角質層に覆われ、 体外からの異物進入を阻止す る構造となっており、 単に有効成分を化粧料に配合しただけでは十分な経皮吸収 性は得られ難い。 これを改良するために、 各種経皮吸収促進剤、 例えば極性化合 物のジメチルスルホキシド、 N—メチルピロリドン、 メチルソ口ソルブ等が提案 されている (特開昭 6 1— 3 3 1 2 9 ) 。 しかし、 これらの経皮吸収促進剤は経 皮吸収性に優れているが、 刺激性、 安定性、 使用感の面で十分であるとはいえな レ、。  In general, the surface of the skin (epidermal) is covered with the stratum corneum, and has a structure that prevents the invasion of foreign substances from outside the body.Sufficient transdermal absorbability can be obtained simply by incorporating the active ingredient into cosmetics. hard. In order to improve this, various percutaneous absorption enhancers, for example, polar compounds such as dimethyl sulfoxide, N-methylpyrrolidone, and methyl sorbate have been proposed (Japanese Patent Application Laid-Open No. 61-331129). However, although these transdermal absorption enhancers are excellent in transdermal absorption, they are not sufficient in terms of irritation, stability, and feeling of use.
一方、 発明者らは、 セドロールに優れた I L 4産生抑制作用による抗アレルギ 一作用があることを見出した (特開 2 0 0 0— 3 0 9 5 2 8 ) 力 水に不溶性の 物質であり、 角質層内へのセドロールの経皮吸収性が十分とはいえない場合が多 かった。  On the other hand, the present inventors have found that cedrol has an antiallergic action due to its excellent inhibitory action on IL4 production (Japanese Unexamined Patent Publication No. 2000-3099528). However, in many cases, transdermal absorption of cedrol into the stratum corneum was not sufficient.
本発明の目的は、 セドロールの経皮吸収性が向上し、 セドロールの効果が十分 に発揮でき、 しかも刺激性のない化粧料を提供することにある。 発明の開示  An object of the present invention is to provide a cosmetic composition in which the transdermal absorbability of cedrol is improved, the effect of cedrol can be sufficiently exerted, and there is no irritation. Disclosure of the invention
本発明者は、 特定の S P値範囲の油剤をセド口ールと併用すると、 セドロール が安定に配合できると同時に、 セドロールを配合した化粧料の抗ァレルギ一 ( I L 4産生抑制) 作用が一段と高められ、 しかも刺激性がないことを見出した。 本発明は、 次の成分 (A) 及び (B ) :  The inventor of the present invention has found that, when an oil agent having a specific SP value range is used in combination with Cedokul, cedrol can be stably compounded, and at the same time, the antiallergic (IL4 production inhibitory) action of a cosmetic containing cedrol is further enhanced. Was found to be non-irritating. The present invention comprises the following components (A) and (B):
(A) セドロール、 ( B ) 総炭素数が 2 2以上であつて S P値が 1 7〜 2 1である油剤 (A) Cedrol, (B) An oil agent with a total carbon number of 22 or more and an SP value of 17 to 21
を含有する化粧料を提供するものである。 発明を実施するための最良の形態 And a cosmetic containing the same. BEST MODE FOR CARRYING OUT THE INVENTION
本発明の化粧料に使用する成分 (A) のセドロールは、 セスキテルペンアルコ ールの 1種であり、光学異性体が存在するが、一般的には式( 1 )で示される( d ) 体で存在する。 本発明の抗アレルギー作用の有効成分であるセドロールとしては Cedrol of component (A) used in the cosmetic of the present invention is a kind of sesquiterpene alcohol, and has an optical isomer, but is generally a (d) isomer represented by the formula (1). Exists in. Cedrol as an active ingredient of the antiallergic effect of the present invention
( d ) 体が好ましいが、 光学異性体である (1 ) 体のもの、 もしくは (d ) 体とThe (d) isomer is preferred, but the optical isomer (1) or the (d) isomer
( 1 ) 体の混在する形態であっても有効性に問題ない。 (1) There is no problem in effectiveness even in the form of mixed body.
Figure imgf000004_0001
セドロールは、 一般にマツ科ヒマラヤスギ属、 ヒノキ科ネズミサシ属、 ビヤク シン属、 クロべ属等の植物の精油に含まれる香料成分として知られている。 シダ 一ウッド油、 ヒバ油等の精油から蒸留等により精製して得ることができ、 また、 合成により得ることもできる。 本発明において使用するセドロールは上記精油精 製品、 合成品のいずれを使用しても良く、 市販品を用いても良い。
Figure imgf000004_0001
Cedrol is generally known as a fragrance component contained in essential oils of plants such as Pinaceae, Cedars, Cypresses, Scorpiones, Prunus, etc. It can be obtained by purifying essential oils such as fern wood oil and hiba oil by distillation or the like, and can also be obtained by synthesis. As the cedrol used in the present invention, any of the above-mentioned essential oil products and synthetic products may be used, or a commercially available product may be used.
成分 (A) のセドロールは、 本発明の化粧料中に 0 . 0 0 1〜1 0重量%、 特 に 0 . 1〜5重量。 /0含有させるのが、 抗アレルギー作用を効果的に発揮できるの で好ましい。 Cedrol of the component (A) is contained in the cosmetic of the present invention in an amount of 0.01 to 10% by weight, particularly 0.1 to 5% by weight. / 0 is preferable because an antiallergic effect can be effectively exerted.
本発明の化粧料に使用する成分 (B ) の油剤は、 総炭素数が 2 2以上であって
Figure imgf000004_0002
7〜2 1のものである。 ここで油剤の S P値とは、 溶解パラメーター δであって、 液体の分子凝集エネルギー Εと分子容 Vから δ = (E/V) 1/2で与 えられる物質定数である。 S P値は、 篠田耕三著 「溶液と溶解度 第 3版」 (丸 善株式会社、 1991年発行) 7 8頁〜に記載の溶解パラメーターの求め方で得られ る。
The oil agent of the component (B) used in the cosmetic of the present invention has a total carbon number of 22 or more.
Figure imgf000004_0002
7 to 21 things. Here, the SP value of the oil agent is the solubility parameter δ, which is a material constant given by δ = (E / V) 1/2 from the molecular cohesion energy 液体 of the liquid and the molecular volume V. The SP value is obtained by the method for obtaining the dissolution parameters described on pages 78 to 78 of “Solutions and Solubility, 3rd Edition” by Kozo Shinoda (Maruzen Co., Ltd., 1991).
成分(Β )の油剤の総炭素数は 2 2以上であるが、特に 2 2〜4 0が好ましく、 また S P値は 25°Cにおいて、 17〜21、特に 17. 0〜19. 0が好ましい。 成分(B)の具体的な例としては、 d 1— α—トコフエロール(総炭素数 29 : SP値 (25°C) 19. 4 (以下同様) ) 、 モノイソステアリン酸モノミリスチ ン酸グリセリル (35 : 1 8. 4) 、 リンゴ酸ジイソステアリル (40 :The total carbon number of the oil agent of the component (Β) is 22 or more, and particularly preferably 22 to 40, Further, the SP value at 25 ° C is preferably from 17 to 21, particularly preferably from 17.0 to 19.0. Specific examples of the component (B) include d 1 -α-tocopherol (total carbon number 29: SP value (25 ° C) 19.4 (the same applies hereinafter)), glyceryl monoisostearate and glyceryl monomyristate (35: 18.4), diisostearyl malate (40:
18. 2) 、 ジカプリン酸ネオペンチルァノレコール (25 : 17. 7) 、 ジカプ リン酸プロピレングリコール (39 : 17. 5) 、 ジノナン酸プロピレングリコ ール (29 : 1 7. 6) 、 テトライソステアリン酸ジグリセリル (60 : 17. 4) 、 デシルテトラデカノール (24 : 17. 9) 、 トリ力プリル酸ダリ セリル (24 : 1 7. 9) 、 トリァセチルリシノール酸グリセリル (63 :18.2), neopentylanolecol dicaprate (25: 17.7), propylene glycol dicaprate (39: 17.5), propylene glycol dinonanoate (29: 17.6), tetraisostearin Acid diglyceryl (60: 17.4), decyltetradecanol (24: 17.9), daliseryl tri-prillate (24: 17.9), glyceryl triacetyl ricinoleate (63:
17. 9) 、 トリイソステアリン酸グリセリル (57 : 17. 2) 、 トリイソス テアリン酸ジグリセリル (60 : 18. 0) 、 トリイソステアリン酸トリメチル プロパン (65 : 17. 2) 、 トリオクタン酸グリセリル (57 : 17. 7) 、 トリカプリン酸グリセリル (33 : 17. 8) 、 ピログルタミン酸イソステアリ ン酸ポリオキシエチレン (25) グリセリルエーテル (175 : 20· 5) 、 プ 口ピオン酸ポリオキシエチレン (2) ミリスチルエーテル (23 : 17. 3) 、 ミリスチン酸ポリオキシエチレン (3) ミリスチルエーテル (34 : 17. 5) 、 ラウロイルグルタミン酸ジォクチルドデシル (57 : 17. 5) 、 リシノレイン 酸セチル (34 : 18. 0 ) 、 リシノレィン酸テトラヒドロフルフリル (28 :17.9), glyceryl triisostearate (57: 17.2), diglyceryl triisostearate (60: 18.0), trimethylpropane triisostearate (65: 17.2), glyceryl trioctanoate (57:17) 7), glyceryl tricaprate (33: 17.8), polyoxyethylene pyrostearate isostearate (25) glyceryl ether (175: 205), polyoxyethylene pionate (2) myristyl ether (23) : 17.3), polyoxyethylene myristate (3) myristyl ether (34: 17.5), dioctyldodecyl lauroylglutamate (57: 17.5), cetyl ricinolate (34: 18.0), ricinolein Acid tetrahydrofurfuryl (28:
19. 3) 、 リノール酸 d 1—ひ一トコフエロール (47 : 17. 5) 、 乳酸ォ クチルドデシル (23 : 18. 5) 、 アジピン酸ジ才クチノレ (22 : 18. 5) 、 ァセチルリシノレイン酸プチル (24 : 17. 3) 、 イソステアリン酸バチル19.3), linoleic acid d 1-hydroxytocopherol (47: 17.5), octyldodecyl lactate (23: 18.5), dithiobutyrate adipate (22: 18.5), butyl acetyl ricinoleate (24: 17.3), Batyl isostearate
(39 : 18. 0) 、 ィソステアリン酸ポリプロピレングリコール (23 :(39: 18.0), polypropylene glycol isostearate (23:
18. 6 )、ポリォキシプロピレン( 10 )セチルエーテル(106 : 18. 4 )、 ォキシステアリン酸オタチル (26 : 18. 3) 、 イソノナン酸イソトリデシル18.6), polyoxypropylene (10) cetyl ether (106: 18.4), octyl oxastearate (26: 18.3), isotridecyl isononanoate
(22 : 1 7. 0) 、 ジィソステアリン酸ポリグリセリル (42〜 1 92 :(22: 17.0), polyglyceryl disostearate (42-192:
19. 4) 等が挙げられる。 19.4) and so on.
成分(B)としては、特にモノィソステアリン酸モノミリスチン酸グリセリル、 リンゴ酸ジィソステアリル、 ジカプリン酸ネオペンチルアルコール、 ジカプリン 酸プロピレングリコール、 ジノナン酸プロピレングリコール、 デシルテトラデカ 9 ノール、 トリカプリル酸グリセリル、 トリカプリン酸グリセリル、 プロピオン酸 ポリオキシエチレン ( 2 ) ミリスチルェ一テル、 ミリスチン酸ポリオキシェチレ ン ( 3 ) ミリスチルエーテル、 リシノレイン酸セチル、 乳酸オタチルドデシル、 アジピン酸ジォクチル、 ァセチルリシノレイン酸ブチル、 ィソステアリン酸ポリ プロピレングリコール、 ォキシステアリン酸ォクチル、 イソノナン酸イソトリデ シルが好ましい。 As component (B), glyceryl monomyristate monoisostearate, diisostearyl malate, neopentyl alcohol dicaprate, propylene glycol dicaprate, propylene glycol dinonanoate, decyltetradecaate are particularly preferred. 9 Nol, glyceryl tricaprylate, glyceryl tricaprate, polyoxyethylene propionate (2) myristyl ether, polyoxyethylene myristate (3) myristyl ether, cetyl ricinoleate, octyldodecyl lactate, dioctyl adipate, acetyl ricinoleate Butyl, polypropylene glycol isostearate, octyl oxastearate, and isotridecyl isononanoate are preferred.
成分 (B ) の油剤は、 2種以上を併用しても良い。 また、 本発明の化粧料中に 0 . 0 0 1〜5 0重量0 /0、 特に 0 . 0 1〜2 0重量0 /0含有するのが好ましい。 本発明の化粧料には、 成分 (B ) 以外の油剤も適宜含有させることができるほ 力 ェデト酸 2ナトリウム、 ェデト酸 3ナトリウム、 クェン酸ナトリウム、 ポリ リン酸ナトリウム、 メタリン酸ナトリウム、 ダルコン酸等の金属封鎖剤;カフェ イン、 タンニン、 トラネキサム酸およびその誘導体;ヒバマタエキス、 ボタンピ エキス、ニンジンエキス、ユーカリエキス、ボダイジュエキス、力ミツレエキス、 ヮレモコゥエキス、 ァスナ口エキス、 ュズェキス、 シャクャクエキス、 ォウノ ク エキス、 タイソゥエキス、 チヨウジエキス、 チヤエキス、 トウキエキス、 ォゥゴ ンェキス、 ョクイニンエキス、 ァノレテアエキス、 ノ、マメリスエキス、 スギナェキ ス、 アロエエキス、 ドクダミエキス、 マロニエエキス、 ノ セリエキス、 ユキノシ タエキス、 スィカズラエキス、 テンチヤエキス、 ノノ ラエキス、 ブナエキス、 ョ モギエキス等の各種エキス類;各種生薬類;ユーカリ油、 ラベンダー油、 ティー ツリー油、 オレンジ油、 セージ油、 ローズマリー油等の精油;酢酸トコフェロー ル、 グリチルリチン酸およぴその誘導体、 ビタミン C等の美白剤;ダリコース、 フルク トース、 トレハロース等の糖類;キサンタンガム、 ヒアルロン酸、 プルラ ン、 ヒ ドロキシセルロース、 カラギーナン、 マンナン等の多糖類;分子量 1 0 0 0以上のポリエチレンダリコール等も適宜含有させることができる。 本発明の化粧料には上記成分以外に、 通常化粧品等の皮膚外用剤に用いられる 成分、 例えば、 保湿剤、 酸化防止剤、 紫外線吸収剤、 界面活性剤、 増粘剤、 アル コール類、 有機酸類、 アルカリ類、 粉末成分、 色剤、 水性成分、 水、 香料、 各種 皮膚栄養剤等を必要に応じて適宜含有させることができる。 Two or more types of oil agents of component (B) may be used in combination. Further, in the cosmetic of the present invention 0. 0 0 1-5 0 weight 0/0, especially 0. 0 1-2 0 weight 0/0 preferably contained. In the cosmetic of the present invention, disodium edetate, sodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, dalconic acid, etc. can be used to appropriately contain an oil agent other than the component (B). Caffeine, tannin, tranexamic acid and derivatives thereof; hibamata extract, botanical extract, carrot extract, eucalyptus extract, bodaiju extract, potato beetle extract, モ remoko ゥ extract, asuna mouth extract, zuzekis, peony extract, ノ ownoku extract, taiso ゥ extract, Citrus extract, Cheer extract, Touki extract, Ogongonkisu, Jokinin extract, Anoretea extract, No, Mameris extract, Suginaesu, Aloe extract, Dokudami extract, Malonie extract, Noceri extract, Yu Various extracts, such as nosita extract, honeysuckle extract, tenchia extract, nonola extract, beech extract, and mugwort extract; various crude drugs; essential oils such as eucalyptus oil, lavender oil, tea tree oil, orange oil, sage oil, and rosemary oil; acetic acid Whitening agents such as tocopherol, glycyrrhizic acid and its derivatives, vitamin C; sugars such as dalicose, fructose and trehalose; polysaccharides such as xanthan gum, hyaluronic acid, pullulan, hydroxycellulose, carrageenan and mannan; Polyethylene dalicol having a molecular weight of 1000 or more can be appropriately contained. In addition to the above-mentioned components, the cosmetics of the present invention also contain components commonly used in external preparations for skin such as cosmetics, for example, humectants, antioxidants, ultraviolet absorbers, surfactants, thickeners, alcohols, and organic compounds. Acids, alkalis, powder components, coloring agents, aqueous components, water, fragrances, various skin nutrients, and the like can be appropriately contained as necessary.
本発明の化粧料は、通常の方法に従って製造することができ、例えばクリーム、 9 乳液、 ローション、 パック、 ジエル等の化粧料として用いることができる。 実施例 The cosmetic of the present invention can be produced according to a usual method, for example, cream, 9 Can be used as cosmetics such as emulsions, lotions, packs, and jewels. Example
実施例 1〜 5 Examples 1 to 5
次の組成の化粧料を常法により調製し、 経皮吸収性及び刺激性を評価した。 (組成) :セドロール 0 . 1 (重量0 /0) 油剤 (表 1 ) 2 A cosmetic having the following composition was prepared by a conventional method, and its transdermal absorption and irritation were evaluated. (Composition):. Cedrol 0 1 (wt 0/0) oil (Table 1) 2
ポリオキシエチレン (6 0 ) 硬化ヒマシ油 2  Polyoxyethylene (60) hydrogenated castor oil 2
ェタノ一ノレ 1 5  Ethanano 1 5
精製水 残量  Purified water balance
(評価方法)  (Evaluation method)
( 1 ) 経皮吸収性:  (1) Percutaneous absorption:
パネラー (1 0名) の上腕部に、 開孔径 1 6 mmの孔のあいたパッチテスト用パ ンソゥ膏を貼った後、 試料 2 0 0 Lを塗布した。 塗布後、 6時間でパンソゥ膏 をはがし、 次いで塗布部をセロハンテープで 1 0回テープストリップビングを行 い、 セロハンテープに密着した角層中のセドロール量を測定した。  A patch test patch with a hole diameter of 16 mm was applied to the upper arm of panelists (10 persons), and 200 L of the sample was applied. After the application, the pansoil was peeled off for 6 hours, and then the applied portion was tape-striped 10 times with a cellophane tape, and the amount of cedrol in the stratum corneum adhered to the cellophane tape was measured.
セドロールの定量は、 1 0枚のセロハンテープからのエタノール抽出物を、 ガ スクロマトグラフィーで測定した。 下記式により経皮吸収率を求め、 判定基準に より判定した。  The quantification of cedrol was measured by gas chromatography of an ethanol extract from 10 cellophane tapes. The percutaneous absorption rate was determined by the following formula, and was determined according to the criteria.
セロハンテープに密着した角層中のセドロール量 (10人の平均値) 経皮吸収率(%) = X 100 塗布したセドロール量 経皮吸収性判定基準: 1 ;経皮吸収率 1 %未満  Cedrol content in the stratum corneum in close contact with the cellophane tape (average value of 10 people) Transdermal absorption rate (%) = X100 Amount of cedrol applied Percutaneous absorption criteria: 1;
2 ;経皮吸収率 1 %以上 2 %未満  2; Percutaneous absorption rate 1% or more and less than 2%
3 ;経皮吸収率 2 %以上 3 %未満  3: Percutaneous absorption 2% or more and less than 3%
4 ;経皮吸収率 '3 %以上  4; Percutaneous absorption rate '3% or more
( 2 ) 刺激性:  (2) Irritation:
敏感肌パネラー (1 0名) が石鹼で洗顔後、 各化粧料を塗布し、 1分後の肌の 状態を、 次の判定基準で評価した。 A;少しでも刺激を感じた人 0名 Sensitive skin panelists (10 people) applied their cosmetics after washing their face with stone stone, and the skin condition 1 minute later was evaluated according to the following criteria. A: 0 people who felt any irritation
B ;少しでも刺激を感じた人 1〜2名  B: 1-2 people who felt a little irritation
C ;少しでも刺激を感じた人 3〜5名  C: 3-5 people who felt any irritation
D ;少しでも刺激を感じた人 6名以上 表 1に結果を示す。 本発明の化粧料はいずれも経皮吸収性に優れ、 刺激もなか つた。  D: 6 or more people who felt slight irritation Table 1 shows the results. All of the cosmetics of the present invention had excellent transdermal absorbability and were not irritating.
Figure imgf000008_0001
実施例 6 (乳液) セドロール 0 ジィソステアリン酸ポリグリセリル 2 5 モノイソステアリン酸モノミリスチン酸グリセリル 2 5 ポリオキシエチレン (2 0 ) 硬化ヒマシ油 2 メチルポリシロキサン ( 6 c s ) 0 5 コレステロール 0 2 ィソステアリン酸コレステリル 0 1 セチノレアノレコーノレ 0 3 ステアリルアルコール 0 2 グリセリン 0 カルボキシビ二ルポリマー
Figure imgf000008_0001
Example 6 (Emulsion) Cedrol 0 Polyglyceryl diisostearate 25 Glyceryl monoisostearate 25 Glyceryl monomyristate 25 Polyoxyethylene (20) hydrogenated castor oil 2 Methyl polysiloxane (6 cs) 0 5 Cholesterol 0 2 Cholesteryl disostearate 0 1 Cetinoreanoconore 0 3 Stearyl alcohol 0 2 Glycerin 0 Carboxyvinyl polymer
(カーボポール 981、 B. F. GOODRICH社製) 0. 2 水酸化力リウム 0. 1 コ /ヽク酸 0. 01 ボタンピエキス  (Carbopol 981, manufactured by B.F. GOODRICH) 0.2 Hydroxy hydroxide 0.1 Co / Pearic acid 0.01 Vegetable extract
(ファノレコレックス ボタンピ£、 一 0. 5 ユー力リエキス  (Fanorecorex buttonpi, one 0.5 yurikuri extract
(ユーカリ抽出液 BGF、 丸善製薬社製) 2. 0 パラォキシ安息香酸エステル 0. 2 精製水  (Eucalyptus extract BGF, manufactured by Maruzen Pharmaceutical Co.) 2.0 Paraoxybenzoic acid ester 0.2 Purified water
実施例 7 (ジエル) セドロール 0. 1 リンゴ酸ジィソステアリル 4 ポリオキシエチレン (40) 硬化ヒマシ油 0. 2 Example 7 (Giel) Cedrol 0.1 Diisostearyl malate 4 Polyoxyethylene (40) hydrogenated castor oil 0.2
グリセリン 6 ェチノレアノレコーノレ 5 力ルポキシビニルポリマー Glycerin 6 Echinoreanorenocore 5 Power lipoxyvinyl polymer
(カーボポール 980、 B. F. GOODRICH社製) 0. 7 アジピン酸 0. 02 水酸化カリゥム 0. 3 アルテアエキス  (Carbopol 980, manufactured by BF GOODRICH) 0.7 Adipic acid 0.02 Potassium hydroxide 0.3 Altea extract
(フアルコレックス アルテア、 一丸フアルコス社製) 1. 0 ヮレモコゥエキス  (Fuarco Rex Altea, manufactured by Ichimaru Fuarcos) 1.0 Remoco Extract
(ジュ抽出液、 丸善製薬社製) 0. 1 力ミツレエキス (力ミツレリキッド、 一丸フアルコス社製) 0. 5 パラォキシ安息香酸ェステル 0. 3 実施例 8 (ローション) セドロール 0. 1 イソノナン酸ィソトリデシル 1. 5 ポリオキシエチレン (60) 硬化ヒマシ油 2 グリセリン 0 トリス (ェトキシェトキシェチル) ホスフエ一卜 2 アタリル酸 ·メタタリル酸アルキル共重合体 (Ju Extract, Maruzen Pharmaceutical Co., Ltd.) 0.1 Power Mitsuru Extract (Power Mitsuru Liquid, Ichimaru Fuarcos Co., Ltd.) 0.5 Paraoxybenzoic acid ester 0.3 Example 8 (Lotion) Cedrol 0.1 Isotridecyl isononanoate 1.5 Polyoxyethylene (60) Hydrogenated castor oil 2 Glycerin 0 Tris (ethoxyxetixethyl) phosphate 2 Ataryl acid / alkyl methacrylate copolymer
(PEMULEN TR- 1、 B. F. GOODRICH社製) 0. 水酸化カリウム 0, 2 アジピン酸 0, 1 ェデト酸 2ナトリゥム 0, 02 シャクャクエキス (シャクャク抽出液、 丸善製薬社製) 0 2 ニンジンエキス (ニンジンエキス K、 丸善製薬社製) 0 05 パラォキシ安息香酸エステル 0 5 精製水  (PEMULEN TR-1, BF GOODRICH) 0. Potassium hydroxide 0,2 Adipic acid 0,1 Edetic acid 2 sodium 2,0 Peony extract (Peony extract, Maruzen Pharmaceutical) 0 2 Carrot extract (Carrot extract K , Maruzen Pharmaceutical Co., Ltd.) 0 05 Paraoxybenzoic acid ester 0 5 Purified water
実施例 9 (クリーム) セドロール 0. 1 ジカプリン酸ネオペンチルアルコーゾレ 3 ステアリン酸ポリグリセリル一 5 3. 5 セチノレアノレコ—ノレ 1. 5 ステアリルアルコール Example 9 (Cream) Cedrol 0.1 Neopentyl alkazolate dicaprate 3 Polyglyceryl stearate 53.5 Cetinorea noreco 1.5 Stearyl alcohol
Ν— (3—へキサデシ口キシー 2—ヒドロキシプロピル)  Ν— (3-hexadecyl oxy-2-hydroxypropyl)
一 Ν— 2—ヒドロキシェチルへキサデ力ナミド 4 コレステロ一ノレ 0. 8 ィソステアリン酸コレステリル 0. 5 グリセリン 20 クェン酸 0. 02 水酸化ナトリゥム 0. 002 トウキエキス (トウキ抽出液 BG、 丸善製薬社製) 0. 1 ュズエキス (ュズ抽出液、 丸善製薬社製) 0. 5 パラオキシ安息香酸エステル 0. 2 フエノキシエタノーノレ 0. 5 実施例 10 (ローション) 1-—2-hydroxyethylhexadenicamide 4 cholesterol monophosphate 0.8 cholesteryl disostearate 0.5 glycerin 20 citrate 0.02 Sodium Hydroxide 0.002 Touki Extract (Touki Extract BG, manufactured by Maruzen Pharmaceutical Co., Ltd.) 0.1 Zuzu Extract (Zuzu Extract, manufactured by Maruzen Pharmaceutical Co., Ltd.) 0.5 Paraoxybenzoic acid ester 0.2 0.2 Phenylethoxyethanol . 5 Example 10 (Lotion)
(重量%) セドロール 0. 01 モノイソステアリン酸モノミ リスチン酸グリセリル 0. 5 ポリオキシエチレン (60) 硬化ヒマシ油 2 グリセリン 5 ジイソステアリン酸ポリグリセリル  (% By weight) Cedrol 0.01 Monomer monoistearate glyceryl ristate 0.5 Polyoxyethylene (60) hydrogenated castor oil 2 glycerin 5 polyglyceryl diisostearate
アタリル酸 ' メタクリル酸アルキル共重合体  Ataryl acid '' alkyl methacrylate copolymer
(PEMULEN TR—1、 Β· F. GOODRICH社製) 0. 1 水酸化カリウム 0. 2 乳酸 0. 1 ェデト酸 2ナトリゥム 0. 02 ョクイニンエキス  (PEMULEN TR-1, manufactured by F. F. GOODRICH) 0.1 Potassium hydroxide 0.2 Lactic acid 0.1 Ethedic acid 2 sodium 0.20 Equinin extract
(ョクイニンリキッド B、 一丸ブアルコス社製) 0. 5 ァスナ口エキス  (Yokuinin liquid B, manufactured by Ichimaru Buarcos) 0.5 Asuna mouth extract
(ァスナロリキッド 一丸フアルコス社製) 2. 0 パラォキシ安息香酸エステル 0. 5 精製水  (Asunaro Liquid, manufactured by Ichimaru Fuarcos) 2.0 Paraoxybenzoic acid ester 0.5 Purified water
実施例 1 1 (油中水型クリーム) セドロール 0. 5 トリカプリル酸グリセリル 1. 5 ノヽ。ノレミチン酸デキストリン 1 N—ラウロイル一 L—グルタミン酸 Example 1 1 (water-in-oil cream) Cedrol 0.5 0.5 glyceryl tricaprylate 1.5 kN. Dextrin noremitate 1 N-lauroyl mono-L-glutamic acid
ジ (コレステリル.オタチルドデシル) 2  Di (cholesteryl. Otatildodecyl) 2
ィソステアリン酸コレステリル 5  Cholesteryl isostearate 5
ォリーブ油 1 0  Olive oil 1 0
セチルー 1, 3—ジメチルブチルエーテノレ 2  Cetyl-1,3-dimethylbutyl ether
- π フキソ酸才: 1 0  -π Fuchsolic acid: 1 0
ジメチルシ口キサン ·メチル (ゥンデシルグリセリルエーテル)  Dimethyl siloxane xan methyl (p-decylglyceryl ether)
シロキサン共重合体 1 5 トリステアリルリン酸ポリオキシエチレン (15) 硬化ヒマシ油 1  Siloxane copolymer 1 5 Polyoxyethylene tristearyl phosphate (15) Hardened castor oil 1
ヒアノレロン酸ナトリウム 1 グリセリン  Sodium hyanoleronate 1 glycerin
ェチルダノレコシド  Etildanorecoside
1 , 2一ペンタンジォーノレ 5 ィソプレングリコーノレ  1,2,1-pentanedione
ラベンダー油  Lavender oil
ドクダミエキス  Dokudami extract
(フアルコレックス ドクダミ 一丸フアルコス社製) 0 . 2 チヨウジエキス  (Falco Rex Dokudami Ichimaru manufactured by Farucos) 0.2 Chiyo extract
(フアルコレックス チヨウジ、 一丸フアルコス社製) 0 パラォキシ安息香酸ェステル 0 3 実施例 6〜 1 1の本発明の化粧料は、いずれもセドロールの経皮吸収性に優れ、 刺激性もない。 産業上の利用可能性  (Fuarcolex Chiyoji, manufactured by Ichimaru Fuarcos Co., Ltd.) 0 Paraoxybenzoic acid ester 03 The cosmetics of the present invention of Examples 6 to 11 are all excellent in transdermal absorption of cedrol and have no irritation. Industrial applicability
本発明のィ匕粧料は、 セドロールの経皮吸収性が向上し、 抗アレルギー (I L 4 産生抑制) 作用に優れ、 刺激性もない。  INDUSTRIAL APPLICABILITY The cosmetic composition of the present invention has improved percutaneous absorption of cedrol, has excellent antiallergic (IL 4 production inhibition) action, and has no irritation.

Claims

請求の範囲 The scope of the claims
1. 次の成分 (A) 及び (B) : 1. The following components (A) and (B):
(A) セドローノレ、  (A) Sedronore,
( B ) 総炭素数が 22以上であつて S P値が 17〜 21である油剤  (B) Oil agent with total carbon number of 22 or more and SP value of 17 to 21
を含有する化粧料。 Cosmetics containing.
2. 成分 (B) ヽ 総炭素数 22〜40の油剤である請求項 1記載の化粧料。 2. The cosmetic according to claim 1, wherein the cosmetic is an oil agent having a total carbon number of 22 to 40.
3. 成分 (B) が、 SP値 17. 0-19. 0の油剤である請求項 1又は 2記載 の化粧料。 3. The cosmetic according to claim 1, wherein the component (B) is an oil having an SP value of 17.0 to 19.0.
4. 成分(A) を 0. 001〜10重量%、成分(B) を 0. 001〜50重量% 含有する請求項 1〜 3のいずれか 1項記載の化粧料。  4. The cosmetic according to any one of claims 1 to 3, comprising 0.001 to 10% by weight of the component (A) and 0.001 to 50% by weight of the component (B).
PCT/JP2002/009269 2001-09-11 2002-09-11 Cosmetic preparation WO2003028673A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001274776 2001-09-11
JP2001-274776 2001-09-11

Publications (1)

Publication Number Publication Date
WO2003028673A1 true WO2003028673A1 (en) 2003-04-10

Family

ID=19099757

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/009269 WO2003028673A1 (en) 2001-09-11 2002-09-11 Cosmetic preparation

Country Status (1)

Country Link
WO (1) WO2003028673A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112870161A (en) * 2021-02-02 2021-06-01 贵州大学 Cedarol nanoemulsion and optimized preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1036246A (en) * 1996-07-24 1998-02-10 Pola Chem Ind Inc Suppressant for melanogenesis and preparation for external use for skin
JPH10194920A (en) * 1996-11-15 1998-07-28 Kao Corp Cosmetic
EP0872228A1 (en) * 1996-08-21 1998-10-21 Kao Corporation Cosmetological methods
WO2001013881A1 (en) * 1999-08-24 2001-03-01 Kao Corporation Cosmetics

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1036246A (en) * 1996-07-24 1998-02-10 Pola Chem Ind Inc Suppressant for melanogenesis and preparation for external use for skin
EP0872228A1 (en) * 1996-08-21 1998-10-21 Kao Corporation Cosmetological methods
JPH10194920A (en) * 1996-11-15 1998-07-28 Kao Corp Cosmetic
WO2001013881A1 (en) * 1999-08-24 2001-03-01 Kao Corporation Cosmetics

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112870161A (en) * 2021-02-02 2021-06-01 贵州大学 Cedarol nanoemulsion and optimized preparation method thereof
CN112870161B (en) * 2021-02-02 2023-03-21 贵州大学 Cedarol nanoemulsion and optimized preparation method thereof

Similar Documents

Publication Publication Date Title
US11491226B2 (en) Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compound
US6866856B2 (en) Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
AU2016202145B2 (en) Methods of Increasing Solubility of Poorly Soluble Compounds and Methods of Making and Using Formulations of Such Compounds
US6346256B1 (en) Stable O/W/O emulsion and its use as a cosmetic and/or dermatological composition
KR20000029011A (en) Composition to enhance skin permeation of topical skin agents
WO2010046291A2 (en) Use of hydroxycinnamic acids and derivatives thereof and/or of plant extracts for treating body odor
US20040228824A1 (en) Cosmetic oil-in-water preparation and use thereof for light skincare
KR100233770B1 (en) Pharmaceutical composition for transdermal administration
DE102009029110A1 (en) Composition, useful e.g. for treating skin and hair and combating microorganisms e.g. Staphylococcus aureus and Malassezia furfur, comprises a functionalized dipeptide and an extract of plant of the family Monimiaceae e.g. Peumus boldus
JP4212220B2 (en) Body odor deodorant
JP2002087926A5 (en)
JP2002087926A (en) Permeation promoting skin care preparation
WO2003028673A1 (en) Cosmetic preparation
JP3723791B2 (en) Cosmetics
JPH1036246A (en) Suppressant for melanogenesis and preparation for external use for skin
JPH09255551A (en) Skin preparation for external use
JP5346540B2 (en) Deodorant / deodorant composition for tobacco odor, and cosmetic composition for hair containing the composition
JPH11292750A (en) Cosmetic
JP2004359603A (en) Cell death inhibitor
JP2002060332A (en) Cosmetic for skin
JP2003081844A (en) Emollient of skin irritation
JP2001072567A (en) Skin cosmetic
JP2003160476A (en) Skin care preparation
JP5137786B2 (en) Cleansing cosmetic containing dimer dilinoleic acid diethylene glycol oligomer ester
JPH1036247A (en) Suppressant for melanogenesis and preparation for external use for skin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS KE KG KP KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase